Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean
Clinical trial NCT03574415 · COMPLETED
Trial details
- NCT number
- NCT03574415
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-01
- Primary completion
- 2019-01-18
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.